STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Innovative Eyewear (LUCYW) Form 144: RSU-Derived Sale on 08/19/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) shows a proposed sale of 1,670 common shares through Raymond James on 08/19/2025 on NASDAQ with an aggregate market value of $3,317.35. The filing reports the securities were acquired as an RSU grant from the issuer on 08/19/2025, with 5,400 units acquired and payment marked as cash. The issuer’s total shares outstanding are listed as 4,574,602. The filer certifies they are not aware of undisclosed material adverse information and indicates no securities sold in the prior three months.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine small insider sale disclosed; transaction size is immaterial to company capitalization.

The filing documents a small proposed sale of 1,670 common shares valued at $3,317.35, originating from RSUs granted and acquired on the same date as the planned sale. Given the issuer's outstanding share count of 4,574,602, the transaction represents a negligible portion of equity and is unlikely to move market valuation. The report appears compliant with Rule 144 disclosure requirements and contains no indicators of material, nonpublic developments.

TL;DR: Disclosure aligns with insider selling rules; signer affirms no undisclosed material information.

The notice properly identifies the broker, planned sale date, and the RSU origin of the shares, and includes the required representation about material nonpublic information. The filing shows no prior sales in the past three months, which is relevant for aggregation rules. This is a routine Section 144 filing and raises no governance red flags based on the provided information.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for LUCYW disclose?

The Form 144 discloses a proposed sale of 1,670 common shares on 08/19/2025 via Raymond James, with aggregate market value of $3,317.35.

How were the shares to be sold for LUCYW acquired?

The shares were acquired as an RSU grant from the issuer on 08/19/2025, listing 5,400 units acquired and payment noted as cash.

On which exchange will the LUCYW shares be sold?

The filing states the sale is to occur on NASDAQ.

Does the Form 144 report any sales in the past three months for the filer?

The filing indicates "Nothing to Report" for securities sold during the past three months.

What is the issuer's total shares outstanding reported in the filing?

The filing lists 4,574,602 shares outstanding.
INNOVATIVE EYEWEAR INC

NASDAQ:LUCYW

LUCYW Rankings

LUCYW Latest News

LUCYW Latest SEC Filings

LUCYW Stock Data

2.00M
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MIAMI